StonvexLoading…
StonvexStonvexStonvexCore line items from STEP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $1.41B | $818.51M | $364.29M | $1.17B |
Operating Income | $-890.83M | $-696.18M | $-20.35M | $-222.03M |
Net Income | $-528.02M | $-404.57M | $-38.42M | $-179.56M |
EPS (Diluted) | $-6.72 | $-5.17 | $-0.49 | $-2.52 |
Total Assets | $5.24B | $5.33B | $4.78B | $4.59B |
Total Liabilities | $4.72B | $4.11B | $3.08B | $2.81B |
Cash & Equivalents | $378.02M | $366.71M | $244.66M | $289.80M |
Free Cash Flow OCF − CapEx | $87.82M | $61.10M | $45.19M | $59.83M |
Shares Outstanding | 78.63M | 78.21M | 77.85M | 71.14M |